Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- ChecktodayChange DetectedStock price panels on the Press Releases investor area updated from NASDAQ $1.28 / TSX $1.79 to NASDAQ $1.15 / TSX $1.61, reflecting current market values.SummaryDifference0.5%

- Check8 days agoChange DetectedThe investor header now displays updated stock quotes, changing NASDAQ from $1.31 to $1.28 and TSX from $1.81 to $1.79.SummaryDifference0.5%

- Check15 days agoChange DetectedUpdated the investor header to reflect current stock prices on NASDAQ and TSX. The NASDAQ price is now $1.31 and the TSX price is $1.81, replacing the previous $1.37 and $1.87.SummaryDifference0.5%

- Check22 days agoChange DetectedStock price values on the investor page were updated (new $1.37 and $1.87; old $1.30 and $1.78 removed). A new press release entry about a Fireside Chat was added to the press releases list, and an older milestone release was deleted.SummaryDifference1%

- Check29 days agoChange DetectedA MAVERIC Phase II results press release entry was added (May 7, 2026) and an ARCHER release from December 1, 2025 was removed. The left stock-price panel updated from $1.355 and $1.84 to $1.30 and $1.78.SummaryDifference1%

- Check36 days agoChange DetectedAdded a new press release entry about expanding MAVERIC Phase III trial network with the date April 28, 2026, and updated the 2026 stock prices on the page. Removed older stock price entries and an older press release about patent allowance dated November 13, 2025.SummaryDifference1%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.